Recilisib sodium
Product Specifications
Target
Akt|||Others|||PI3K
Related Pathways
Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling|||Others
Bioactivity
Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis.
Smiles
[Na].OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1
Molecular Formula
C16H13ClNaO4S
Molecular Weight
359.78
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/87935890-C2AE-4199-9FA1-8D392EC2FD44/T13862L
CAS Number
922139-31-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-342885 250 mg
2-mercapto-5- (4-methylphenyl) -3- (tetrahydrofuran-2-ylmethyl) thieno[2,3-d]pyrimidin-4 (3H) -one
Ask
View Details 
FA-1009-NE 12 Samples
Metal Toxicity TF Activation Profiling Plate Array + Nuclear Extraction Kit
Ask
View Details 
E46F61324 40 µL
Chromodomain helicase DNA binding 4 Rabbit Monoclonal Antibody [KD Validated]
Ask
View Details